Therapy enhancing chromosome instability may be advantageous for IDH1 R132H/WT gliomas
{{output}}
Recently revised brain tumor classification suggested a glioma treatment strategy that takes into consideration molecular variants in IDH1 and TP53 marker genes. While pathogenic variants of IDH1 and TP53 can be accompanied by chromosomal instability (CIN), th... ...
